Final Development of the First Generic Quality of Life and Symptoms Measure Specific for Hematological Malignancies: The HM-PRO

被引：1
|
作者：
Goswami, Pushpendra [1 ]
Ionova, Tatiana [2 ,3 ]
Oliva, Esther Natalie [4 ]
Else, Roger [5 ]
Kell, Jonathan [6 ]
Fielding, Adele K. [7 ]
Jennings, Daniel [8 ]
Karakantza, Marina [9 ]
Al-Ismail, Saad [10 ]
Collins, Graham P. [11 ]
McConnell, Stewart [9 ]
Langton, Catherine [9 ]
Salek, Sam [12 ]
机构：
[1] Univ Hertfordshire, Life & Med Sci, Hatfield, Herts, England
[2] St Petersburg State Univ, Univ Clin, St Petersburg, Russia
[3] Multinat Ctr Qual Life Res, St Petersburg, Russia
[4] Grande Osped Metropolitano, Div Hematol, Reggio Di Calabria, Italy
[5] Patient Res Partner, Milton Keynes, Bucks, England
[6] Univ Hosp Wales, Cardiff, Wales
[7] UCL, Inst Canc, London, England
[8] Royal Surrey Cty Hosp NHS Fdn Trust, Guildford, Surrey, England
[9] Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England
[10] Abertawe Bro Morgannwg Univ NHS Trust Singleton H, Haematol, Swansea, W Glam, Wales
[11] Oxford Univ Hosp NHS Trust, Oxford, England
[12] Univ Hertfordshire, Hatfield, Herts, England
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-129030
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3484
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Development of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Content Validity
    Goswami, Pushpendra
    Oliva, Esther N.
    Ionova, Tatyana
    Else, Roger
    Kell, Jonathan
    Fielding, Adele K.
    Jennings, Daniel M.
    Karakantza, Marina
    Al-Ismail, Saad
    Collins, Graham P.
    McConnell, Stewart
    Langton, Catherine
    Salek, Sam
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [2] Reliability of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure: HM-PRO
    Goswami, Pushpendra
    Oliva, Esther N.
    Ionova, Tatyana
    Else, Roger
    Kell, Jonathan
    Fielding, Adele K.
    Jennings, Daniel M.
    Karakantza, Marina
    Al-Ismail, Saad
    Collins, Graham P.
    McConnell, Stewart
    Langton, Catherine
    Al-Obaidi, Magda J.
    Oblak, Metod
    Salek, Sam
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [3] Responsiveness and the Minimal Clinically Important Difference for HM-PRO in Patients with Hematological Malignancies
    Goswami, Pushpendra
    Oliva, Esther Natalie
    Ionova, Tatyana
    Salek, Sam
    BLOOD, 2018, 132
  • [4] Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Construct Validity Study
    Goswami, Pushpendra
    Oliva, Esther N.
    Ionova, Tatyana
    Else, Roger
    Kell, Jonathan
    Fielding, Adele K.
    Jennings, Daniel M.
    Karakantza, Marina
    Al-Ismail, Saad
    Collins, Graham P.
    McConnell, Stewart
    Langton, Catherine
    Al-Obaidi, Magda J.
    Oblak, Metod
    Salek, Sam
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [5] Development of HM-PRO, a haematology specific Patient-Reported Outcome Measure: content validation
    Goswami, Pushpendra
    Salek, Sam
    Ionova, Tatyana
    Oliva, Esther
    Kell, Jonathan
    Karakantza, Marina
    Al-Ismail, Saad
    Collins, Graham P.
    McConnell, Stewart
    Langton, Catherine
    Jennings, Daniel M.
    Else, Roger
    Fielding, Adele K.
    QUALITY OF LIFE RESEARCH, 2017, 26 (01) : 130 - 130
  • [6] Translating the Science of Patient Reported Outcomes into Practice: Meaningfulness of HM-PRO Scores in Patients with Hematological Malignancies
    Goswami, Pushpendra
    Oliva, Esther Natalie
    Ionova, Tatyana
    Salek, Sam
    BLOOD, 2018, 132
  • [7] HM-PRO: A Novel Patient-Reported Outcome Measure in Hematological Malignancy for Use in Clinical Practice
    Goswami, Pushpendra
    Salek, Sam
    Ionova, Tatyana
    Oliva, Esther Natalie
    Fielding, Adele K.
    Karakantza, Marina
    Al-Ismail, Saad
    Collins, Graham
    McConnell, Stewart
    Langton, Catherine
    Jennings, Daniel
    Else, Roger
    Kell, William J.
    BLOOD, 2017, 130
  • [8] DEVELOPMENT OF A NEW HAEMATOLOGICAL MALIGNANT PATIENT-REPORTED OUTCOME MEASURE FOR USE IN CLINICAL PRACTICE: HM-PRO
    Goswami, P.
    Salek, S.
    Ionova, T.
    Oliva, E.
    Fielding, A. K.
    Karakantza, M.
    Al-Ismail, S.
    Collins, G. P.
    McConnell, S.
    Langton, C.
    Jennings, D. M.
    Else, R.
    Kell, J.
    HAEMATOLOGICA, 2017, 102 : 602 - 602
  • [9] SYMPTOMS AND THEIR ASSOCIATION WITH QUALITY OF LIFE IMPAIRMENT IN ADVANCED HEMATOLOGICAL MALIGNANCIES
    Novik, A.
    Ionova, T.
    Kalyadina, S.
    kishtovich, A.
    Fedorenko, D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 316 - 316
  • [10] Real-World Evidence of Collecting Quality of Life (QoL) and Symptoms Perception Using the HM-PRO© Tool As a Patient-Reported Outcome Measure (PROM) in Patients with Lymphoma While Receiving Intravenous Chemotherapy
    Castilla Garcia, Lucia
    Ramos Cillan, Sergio
    Lopez Garcia, Alberto
    Barreras Ruiz, Natalia
    Castillo Bazan, Eva
    Pascual, Adriana
    Riesco Ovelar, Miriam
    Urrutia, Celia
    Cruz, Susana
    Pardo, Alberto
    Herrero, Antonio
    Perez Saenz, Maria Angeles
    Morillo Gilles, Daniel
    Llamas Sillero, Maria Pilar
    Becares, Javier
    Barriocanal, Carla
    Short Apellaniz, Jorge
    del Olmo, Marta
    Arcos Campillo, Javier
    Cordoba, Raul
    BLOOD, 2022, 140 : 5164 - 5166
12345